Navigation Links
MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
Date:6/15/2012

SAN DIEGO, June 15, 2012 /PRNewswire/ -- MedVantx, Inc., the company that created the first ever controlled access to generic samples in US physician offices, today highlighted it's MedStart cabinet as a solution to the problem highlighted in a recent study published in the Journal of the American Board of Family Medicine.  In the study, researchers reported that physician offices often lack the controls and tools to appropriately manage pharmaceutical samples onsite, including tracking lot number and expiration, as well as the ability to identify historical sampled patient data in the event of manufacturer product recalls.  Nearly 30% of the drug packages in one of the clinics evaluated in the study were expired.

MedVantx provides a first-of-its-kind capability for controlled access and tracking of sample medications, including generics, in US physician offices with its proprietary automated ATM-like cabinet, MedStart™.  The MedStart™ cabinet automates the traditional pharmaceutical sampling process for physicians and the MedStart Patient Profile Link™ interface captures physician sampling data in the patients' health plan electronic medical record.  Through MedStart, doctors can provide patients with generic, brand and OTC samples covering the majority of common acute and chronic conditions while the patient is in the office.  The cabinet's bar code technology automatically captures medication lot number, expiration date information and provides a web-based patient specific registry of individual physician sampling history that can be used by physicians and health systems in the event of a medication recall. 

"As the prescribing process becomes more and more technologically advanced, it's amazing that the majority of physicians' offices and health systems lack automated sample management tools and are still tracking the sample medication use process with paper, pen and clip boards," said Nicole Cardosa, MedVantx Vice President of Physician Sales.  "The fact that in this day and age, medication samples are given to patients without any integration into their online medical record is really one of the last open quality issues in the medication use process.  Physicians, health systems and payors now have the opportunity to use MedVantx patient specific sample medication data to increase patient adherence, reduce gaps in care and enhance safety."

As reported in the May-June issue of the Journal of the American Board of Family Medicine, researchers took inventories of the drug sample closets at 10 primary care clinics in the Phoenix metropolitan area. Of the 12,581 sample boxes or packages examined, 14% were expired. (ncbi.nlm.nih.gov/pubmed/22570403/).

About MedVantx, Inc.

MedVantx is an innovative consumer medication management and delivery company committed to streamlining access, reducing costs and providing highly relevant information to benefit patients, physicians, health plans, employers and manufacturers.  The MedVantx platform is a fully automated / integrated point of care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel - the physician's office sample closet.  The Company's consumer medication management platform includes free initial prescription and over-the-counter medication therapy at the point of care; a consumer helpline providing drug information, adherence management and reimbursement assistance; and convenient consumer home delivery through its mail order pharmacy. MedVantx has served over 3.5 million consumers through an integrated network including health plans, manufacturers and more than 3,500 prescribers.  For additional information about MedVantx visit www.medvantx.com.

Contact:
JD Haldeman
(858) 625-2990 ext. 130
JD.Haldeman@MedVantx.com


'/>"/>
SOURCE MedVantx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Problems Plague Medicares Method for Measuring Payment Errors
2. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
3. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
4. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
5. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
6. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
7. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
8. Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting
9. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
10. FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits with More Frequent Home Hemodialysis with the NxStage System One
11. Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Orthopedic Implants (Including Spinal Implants, ... to Gain a Significant Market Share Owing to a Large ... ... According to a new report by Persistence ... Packaging: Clamshell Product Type Segment Projected to Witness a Significantly ...
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... at 5,251.11, down 1.36%; the Dow Jones Industrial Average edged ... closed at 2,191.08, down 0.35%. Losses were broad based as ... Today, Stock-Callers.com has initiated research reports on the following Services ... N.V. (NASDAQ: QGEN ), INC Research Holdings Inc. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh ... generation fits into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, ... showing how the details line up exactly with Bible Prophecy – a protected way ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today CloudMine, a secure, ... was named the best Sales Team of 2016 as part of the 2016 ... by the Software & Information Industry Association (SIIA), the principal trade association for ...
(Date:12/2/2016)... FL (PRWEB) , ... December 02, 2016 , ... ‘Tis ... are winners of $1,000 each from the National Family Partnership and the Drug Enforcement ... families who decorated their homes and the 10 winning schools who decorated their campuses ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
Breaking Medicine News(10 mins):